In certain genetic human cystic kidney diseases, such as autosomal dominant PKD (ADPKD) associated with PKD1 or PKD2 mutations, in vivo kidney cystogenesis is largely driven by cAMP signaling (Richards et al., 2021). This evidence concerns the gene PKD1 and autosomal dominant polycystic kidney disease.